Compound Detail
CHEMBL5275465
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5275465 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | IAFBETLGGDHENG-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
266.6
MW (Da)
3.55
ALogP
2
HBA
2
HBD
57.5
PSA (Ų)
0.87
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.66
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 4.66 | 4.66 | 21700.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 21700.0 | nM | 4.66 | Inhibition of acid-induced fibrillogenesis of human Transthyretin Y78F mutant ex... | 33091848 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33091848 | 10.1016/j.bmc.2020.115794 | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine